Home / Intelligence / Webinars / Elevating Commercialization in China Part 1: The Path to Launch
Available On Demand
The pharmaceutical market in China has experienced tremendous growth over the past several decades and is becoming increasingly important. While many life sciences organizations consider China to be a ‘must win’ market, commercial success can be elusive. Despite the large patient base and recent economic and political tailwinds driving the advancement of the healthcare industry, sales for innovative drugs in China are often only a fraction of those in the U.S. The complex and rapidly evolving market dynamics require companies to stay on the cutting edge of new regulatory pathways, pricing/market access and go-to-market models.
Join Trinity Life Sciences’ APAC experts as they explore the key dynamics of the pharmaceutical market in China and uncover multiple strategies and levers that can elevate commercial success in this market.
In this three-part webinar series, our experts will explore:
Part 1: The Path to Launch | Available On Demand
Leveraging novel commercialization pathways for innovative therapies
Part 2: The Key to Pricing & Access Optimization | October 18th or 19th
Decoding the current dynamics and future trends of Pricing and Market Access
Part 3: The Winning Commercial Model | Upcoming
Building a model to match China’s changing dynamics
Key Topics Covered In Part 1:
- Regulatory pathways to accelerate commercial launch in China
- Balancing pros and cons
- Insights from recent launches
Featuring
Andy Wong
Partner
Tony Xu
Engagement Manager
Yitong Li
Senior Consultant & APAC Expert,
Strategic Advisory
Complete the form below to view the on-demand webinar:
By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.
Related Intelligence
Blog
Beyond the Price Tag: Understanding Colombia’s New Pricing Policy
In August 2023, the Colombian government published a new pricing policy outlining that the list price of new medicines in Colombia will be established based on their therapeutic value category, resulting from an assessment conducted by the Instituto de Evaluation Tecnológica en Salud (IETS). The outcomes of the therapeutic assessment are then reported to the […]
Read More
White Papers
2022 NRDL Pricing Implementation and Access Outcomes in China
The pricing and market access (P&MA) landscape in China has been rapidly evolving as the country continuously attempts to balance rewarding innovation and sustainability of healthcare funding. China represents a unique and dynamic market archetype for manufacturers especially in terms of P&MA strategies. China’s aging population (≥60 years) is estimated to exceed 400 million by […]
Read More
Webinars
Elevating Commercialization in China Part 2: The Key to Pricing and Access Optimization
Available On Demand
In Part 1 of this webinar series, The Path to Launch, we discussed various pathways and innovative programs to accelerate product launch in China. However, launching a product is only half of the battle. Ensuring optimal access to deliver the treatment to more patients is also critical for commercial success. Join Trinity Life Sciences’ APAC experts […]
Watch Now